Outcomes of radical cystectomy

BJU International

Volumn 102, Issue 9B, 2008, Pages 1279-1288

  Thalmann, George N ^a   Stein, John P ^a  

^a Inselpital Bern ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT THERAPY; BLADDER CANCER; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CYSTECTOMY; FOLLOW UP; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; LAPAROSCOPY; LYMPH NODE METASTASIS; LYMPHOCELE; LYMPHOMA; MORBIDITY; MORTALITY; OPERATION DURATION; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PERCUTANEOUS DRAINAGE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PYELONEPHRITIS; QUALITY OF LIFE; REVIEW; SEMINAL VESICLE; SOCIOECONOMICS; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL; THERAPY DELAY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA TUMOR; URINARY DIVERSION; URINARY TRACT TUMOR;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIALS AS TOPIC; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PELVIS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 54049149933     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07971.x     Document Type: Review

References (89)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics 2008. CA Cancer J Clin 2008 58 : 71 96
2. Prout G, Marshall VF. The prognosis with untreated bladder tumors. Cancer 1956 9 : 551 8
3. Montie JE, Straffon RA, Stewart BH. Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984 131 : 477 82
4. Lerner SP, Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol Clin North Am 1992 19 : 713 23.
5. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001 19 : 666 75
6. Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003 21 : 690 6
7. Sanchez-Ortiz RF, Huang W, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 2003 169 : 110 5
8. Hautmann RE, Paiss T. Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 1998 159 : 1845 50
9. Chang SS, Hassan M, Cookson MS, Wells N, Smith JA Jr. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 2003 170 : 1085 7
10. Muhmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 2006 175 : 78 83
11. Turner WH, Studer UE. Cystectomy and urinary diversion. Semin Surg Oncol 1997 13 : 350 8
12. Skinner EC, Stein JP, Skinner DG. Surgical benchmarks for the treatment of invasive bladder cancer. Urol Oncol 2007 25 : 66 71
13. Dhar NB, Kessler TM, Mills RD, Burkhard FC, Studer UE. Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients. Eur Urol 2007 52 : 1006 14
14. Lerner SP, Skinner DG, Lieskovsky G et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 1993 149 : 758 64
15. Vieweg J, Gschwend JE, Herr HW, Fair WR. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999 161 : 449 54
16. Ghoneim MA, el-Mekresh MM, el-Baz MA, el-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1026 cases. J Urol 1997 158 : 393 9
17. Herr HW, Faulkner JR, Grossman HB et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004 22 : 2781 9
18. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008 179 : 873 8
19. Basillote JB, Abdelshehid C, Ahlering TE et al. Laparoscopic assisted radical cystectomy with ileal neobladder: a comparison with the open approach. J Urol 2004 172 : 489 93
20. Cathelineau X, Arroyo C, Rozet F et al. Laparoscopic assisted radical cystectomy: the Montsouris experience after 84 cases. Eur Urol 2005 47 : 780 4
21. Gerullis H, Kuemmel C, Popken G. Laparoscopic cystectomy with extracorporeal-assisted urinary diversion: experience with 34 patients. Eur Urol 2007 51 : 193 8
22. Finelli A, Gill IS, Desai MM, Moinzadeh A, Magi-Galluzzi C, Kaouk JH. Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. J Urol 2004 172 : 1809 12
23. Guru KA, Kim HL, Piacente PM, Mohler JL. Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute. Urology 2007 69 : 469 74
24. Birkmeyer JD, Stukel TA, Siewers AE et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003 349 : 2117 27
25. Konety BR, Dhawan V, Allareddy V et al. Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper? J Urol 2004 172 : 1056 61
26. Kessler TM, Burkhard FC, Perimenis P et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004 172 : 1323 7
27. Hautmann RE, Stein JP. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol Clin North Am 2005 32 : 177 85
28. Thalmann GN. Practice point. Should the uterus and ovaries be removed, and the vagina resected, routinely during radical cystectomy? Nat Clin Pract Urol 2005 2 : 14 5
29. Stein JP, Cote RJ, Freeman JA et al. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol 1995 154 : 1329 33
30. Hautmann RE, Gschwend JE, de Petriconi RC et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006 176 : 486 92
31. Haleblian G, Skinner EC, Dickinson MG et al. Hydronephrosis as a prognostic indicator in bladder cancer patients. J Urol 1998 160 : 2011 4
32. Quek ML, Stein JP, Daneshmand S et al. A critical analysis of perioperative mortality from radical cystectomy. J Urol 2006 175 : 886 9
33. Figueroa AJ, Stein JP, Dickinson M et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 1998 83 : 141 7
34. Chang SS, Alberts G, Cookson MS et al. Radical cystectomy is safe in elderly patients at high risk. J Urol 2001 166 : 938 41
35. Studer UE, Burkhard FC, Schumacher M et al. Twenty years experience with an ileal orthotopic low pressure bladder substitute - lessons to be learned. J Urol 2006 176 : 161 6
36. Berger A, Aron M. Laparoscopic radical cystectomy: long-term outcomes. Curr Opin Urol 2008 18 : 167 72
37. Haber GP, Crouzet S, Gill IS. Laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis. Eur Urol 2008 54 : 54 64
38. Kane CJ. Laparoscopic radical cystectomy for cancer; oncologic outcomes for up to 5 years Haber GP, Gill IS, Section of Laparoscopic and Robotic Surgery, Glickman Urological Institute, The Cleveland Clinic Foundation, Cleveland, OH. Urol Oncol 2008 26 : 221
39. Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006 176 : 2414 22
40. Bassi PF, Gianluca DR, Ferfunte A et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 1999 161 : 1494 7
41. Rodriguez O, Palou J, Urdaneta G et al. An analysis of prognostic factors in patients with PT0 disease following radical cystectomy and long term follow-up. J Urol 2007 177 (Suppl. 499, abstract 1514
42. Colombo R, Briganti A, Sozzi F et al. Clinical outcome and factors predicting cancer specific survival of patients with PT0 disease following radical cystectomy. J Urol 2007 177 (Suppl. 499 500, abstract 1515
43. Volkmer BG, Kuefer R, Bartsch G et al. Effect of a pT0 Cystectomy Specimen without Neoadjuvant Therapy on Survival. Cancer 2005 104 : 2384 91
44. Palapattu GS, Shariat SF, Karakiewicz PI et al. Bladder Cancer Research Consortium. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 2006 175 : 1645 9
45. Poulsen AL, Horn T, Steven K. Radical cystectomy; extending limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998 160 : 2015 9
46. Vieweg J, Gschwend JE, Herr HW, Fair WR. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999 161 : 72 6
47. Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004 171 : 1830 4
48. Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004 172 : 85 9
49. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004 171 : 139 44
50. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data base. J Urol 2003 169 : 946 50
51. Gupta A, Lotan Y, Bastian PJ et al. Bladder Cancer Research Consortium. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology 2008 71 : 302 7
52. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic lymph node dissection can make a difference. J Urol 1982 128 : 34 6
53. Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2001 166 : 19 23
54. Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001 165 : 62 4
55. Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003 170 : 35 41
56. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003 169 : 943 5
57. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int 2000 85 : 817 23
58. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on the outcome in patients with muscle invasive bladder cancer. J Urol 2001 167 : 1295 8
59. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001 166 : 2295 6
60. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor J Clin Oncol 2005 23 : 2358 65
61. Palou J, Rodríguez O, Algaba F et al. Disease specific survival is not related to stage in patients with positive lymphovascular invasion in cystectomy specimens. J Urol 2007 177 (Suppl. 552, abstract 1664
62. Luongo T, Ayyathurai R, Nieder AM et al. Lymphovascular invasion in bladder cancer - is it an important prognostic indicator? J Urol 2007 177 (Suppl. 552, abstract 1665
63. Quek ML, Stein JP, Nichols PW et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005 174 : 103 6
64. Lotan Y, Gupta A, Shariat SF et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005 23 : 6533 9
65. Kunju LP, You L, Zhang Y et al. Comparison of lymphovascular invasion in TURBT and radical cystectomy specimens from patients with urothelial carcinoma. J Urol 2007 177 (Suppl. 502, abstract 1520
66. Volkmer BG, Küfer R, Maier S et al. Outcome in patients with seminal vesicle invasion after radical cystectomy. Outcome in patients with seminal vesicle invasion after radical cystectomy. J Urol 2003 169 : 1299 302
67. Schuster TG, Smith DC, Montie JE. Pelvic recurrences post cystectomy: current treatment strategies. Semin Urol Oncol 2001 19 : 45 50
68. Dhar NB, Jones JS, Reuther AM et al. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. BJU Int 2007 101 : 969 72
69. Skinner DG, Lieskovsky G. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 1984 131 : 1069 72
70. Colleselli K, Stenzl A, Eder R, Strasser H, Poisel S, Bartsch G. The female urethral sphincter: a morphological and topographical study. J Urol 1998 160 : 49 50
71. Stein JP, Esrig D, Freeman JA et al. Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women. Urology 1998 51 : 951 5
72. Freeman JA, Tarter TA, Esrig D et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 1996 156 : 1615 9
73. Ali-El-Dein B, Abdel-Latif M, Ashamallah A, Abdel-Rahim M, Ghoneim M. Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study. J Urol 2004 171 : 275 8
74. Lee CT, Hafez KS, Sheffield JH, Joshi DP, Montie JE. Orthotopic bladder substitution in women: nontraditional applications. J Urol 2004 171 : 1585 8
75. Stenzl A, Jarolim L, Coloby P et al. Urethra-sparing cystectomy and orthotopic urinary diversion in women with malignant pelvic tumors. Cancer 2001 92 : 1864 71
76. Varol C, Thalmann GN, Burkhard FC, Studer UE. Treatment of urethral recurrence following cystectomy and ileal bladder substitution. J Urol 2004 172 : 937 42
77. Meissner C, Giannarini G, Schumacher MC, Thoeny H, Studer UE, Burkhard FC. The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol 2007 178 : 2287 90
78. Tran W, Serio AM, Raj GV et al. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. J Urol 2008 179 : 96 100
79. Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1069 patients with 10-year followup. J Urol 2007 177 : 2088 94
80. Thalmann GN, Markwalder R, Walter B, Studer UE. Long term experience with BCG therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol 2002 168 : 1381 5
81. Gilbert SM, Wood DP, Dunn RL et al. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer 2007 109 : 1756 62
82. Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer 2006 106 : 2355 62
83. Månsson A, Al Amin M, Malmström PU, Wijkström H, Abol Enein H, Månsson W. Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution - a prospective comparative study. Urology 2007 70 : 1086 90
84. Chamie K, Hu B, Devere White RW, Ellison LM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008 102 : 284 90. April Epub ahead of print
85. Hollenbeck BK, Miller DC, Taub D et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004 64 : 292 7
86. Nielsen ME, Shariat SF, Karakiewicz PI et al. Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007 51 : 699 706
87. Horstmann M, Witthuhn R, Falk M, Stenzl A. Sex specific differences in bladder cancer. J Urol 2007 177 (Suppl. 357, abstract 1081
88. Prout GR Wesley MN, McCarron PG et al. Survival experience of black patients and white patients with bladder carcinoma. Cancer 2004 100 : 621 30
89. Begum G, Dunn JA, Bryan RT, Bathers S, Wallace DM. West Midlands Urological Research Group Socio-economic deprivation and survival in bladder cancer. BJU Int 2004 94 : 539 43